BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15142061)

  • 1. The assessment of topical nasal drug distribution.
    Aggarwal R; Cardozo A; Homer JJ
    Clin Otolaryngol Allied Sci; 2004 Jun; 29(3):201-5. PubMed ID: 15142061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of inferior turbinate hypertrophy on nasal spray distribution to the middle meatus.
    Dowley AC; Homer JJ
    Clin Otolaryngol Allied Sci; 2001 Dec; 26(6):488-90. PubMed ID: 11843929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery to paranasal sinuses using pulsating aerosols.
    Möller W; Schuschnig U; Bartenstein P; Meyer G; Häussinger K; Schmid O; Becker S
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):255-63. PubMed ID: 25084017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulsating airflow and drug delivery to paranasal sinuses.
    Möller W; Lübbers C; Münzing W; Canis M
    Curr Opin Otolaryngol Head Neck Surg; 2011 Feb; 19(1):48-53. PubMed ID: 21178621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical potential of pulsating aerosol for sinus drug delivery.
    Möller W; Münzing W; Canis M
    Expert Opin Drug Deliv; 2010 Nov; 7(11):1239-45. PubMed ID: 20874262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery to the nasal cavity: in vitro and in vivo assessment.
    Newman SP; Pitcairn GR; Dalby RN
    Crit Rev Ther Drug Carrier Syst; 2004; 21(1):21-66. PubMed ID: 15099184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of delivery of topical medications to the paranasal sinuses via "vertex-to-floor" position and atomizer spray after FESS.
    Cannady SB; Batra PS; Citardi MJ; Lanza DC
    Otolaryngol Head Neck Surg; 2005 Nov; 133(5):735-40. PubMed ID: 16274802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of fluticasone exhalation delivery system in the management of chronic rhinosinusitis: what is the evidence?
    Kuan EC; Kovacs AJ; Workman AD; Bosso JV; Adappa ND
    Int Forum Allergy Rhinol; 2019 May; 9(S1):S16-S21. PubMed ID: 31087635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy.
    Ragab SM; Lund VJ; Saleh HA; Scadding G
    Allergy; 2006 Jun; 61(6):717-24. PubMed ID: 16677241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the nasal cavity in rhinitis and sinusitis.
    Kantar A
    Int J Immunopathol Pharmacol; 2010; 23(1 Suppl):67-9. PubMed ID: 20152085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel drug-delivery systems for patients with chronic rhinosinusitis.
    Albu S
    Drug Des Devel Ther; 2012; 6():125-32. PubMed ID: 22745531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of three-drug delivery modalities on olfactory function in chronic sinusitis.
    Reychler G; Colbrant C; Huart C; Le Guellec S; Vecellio L; Liistro G; Rombaux P
    Laryngoscope; 2015 Mar; 125(3):549-55. PubMed ID: 25224684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsating aerosols for drug delivery to the sinuses in healthy volunteers.
    Möller W; Schuschnig U; Khadem Saba G; Meyer G; Junge-Hülsing B; Keller M; Häussinger K
    Otolaryngol Head Neck Surg; 2010 Mar; 142(3):382-8. PubMed ID: 20172385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glucan solution nasal spray vs saline in the treatment of chronic rhinosinusitis: a multi-centric double blind randomised clinical trial].
    Passali D; Fiorella R; Camaioni A; Villari G; Mora E; Passali GC; Passali FM; Crisanti A; Bellussi L
    Clin Ter; 2007; 158(2):139-45. PubMed ID: 17566515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric atrophic rhinosinusitis: what can we do?
    Magalhães C; Viana M; Alves V; Nakamura R; Duarte D
    Int J Pediatr Otorhinolaryngol; 2015 May; 79(5):763-5. PubMed ID: 25799383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intranasal steroid therapy in inflammatory nasal-sinus pathology in pediatric age].
    Berlucchi M; Tomenzoli D
    Minerva Pediatr; 2009 Jun; 61(3):323-31. PubMed ID: 19461575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality topical therapy for refractory chronic rhinosinusitis: our experience in thirteen patients with and twelve patients without nasal polyps.
    Shikani AH; Kourelis K; Alqudah MA; Shikani HJ; Cope E; Kirk N; Bergstedt D; Basaraba RJ; Leid JG
    Clin Otolaryngol; 2013 Jun; 38(3):254-8. PubMed ID: 23398898
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical therapy in the management of chronic rhinosinusitis.
    Huang A; Govindaraj S
    Curr Opin Otolaryngol Head Neck Surg; 2013 Feb; 21(1):31-8. PubMed ID: 23277167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of functional endoscopic sinus surgery on nasal spray distribution to the middle meatus in patients with rhinosinusitis.
    Tsikoudas A; Barnes ML; White PS
    Am J Rhinol Allergy; 2009; 23(5):546-8. PubMed ID: 19807991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Devices for aerosol delivery to treat sinusitis.
    Laube BL
    J Aerosol Med; 2007; 20 Suppl 1():S5-17; discussion S17-8. PubMed ID: 17411406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.